Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

PHOspholamban RElated CArdiomyopathy STudy - Intervention (i-PHORECAST)

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by University Medical Center Groningen
Sponsor:
Collaborators:
Netherlands: TCC, Trial Coordination Center UMCG
The Interuniversity Cardiology Institute of the Netherlands
ZonMw: The Netherlands Organisation for Health Research and Development
Netherlands: CVON, CardioVascular Research Netherlands
Information provided by (Responsible Party):
M.p. van den Berg, MD, PhD, professor in Cardiology, University Medical Center Groningen
ClinicalTrials.gov Identifier:
NCT01857856
First received: May 8, 2013
Last updated: October 24, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2020
  Estimated Primary Completion Date: January 2020 (Final data collection date for primary outcome measure)